先端分野の市場情報を提供する株式会社グローバルインフォメーション（神奈川県川崎市、代表取締役社長：小野 悟）は、2013年5月14～16日 米国、シアトルにて開催されるIBC Life Sciences主催 国際学会「Biological Assay Development, Validation & Maintenance 2013}の代理店と ...

The Association for Molecular Pathology (AMP) has published a set of 13 best practice recommendations for validating and reporting clinical circulating tumor DNA (ctDNA) or liquid biopsy assays and ...

The last two decades have witnessed the steady growth of the protein drug market. As original recombinant products come off patent, generics/ biosimilars are also beginning to be manufactured. The ...

A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium was published in JCO ...

Dr Jeff Cummings PhD is a Staff Scientist working within the Clinical and Experimental Pharmacology Group of the Cancer Research UK Manchester Institute as its quality assurance (QA) manager. Jeff has ...

Figure 8: Major analytical performance measurements of the NeXT Personal assay. “NeXT Personal uses whole genome sequencing of tumor and matched normal samples combined with advanced analytics to ...

Cancer biomarkers span a broad biological spectrum, including proteins, metabolites, and nucleic acids detectable in samples such as tissue biopsies and blood. 1 At the beginning of a biomarker ...

CEO Sujal Patel highlighted progress in advancing Nautilus' proteome analysis platform, focusing on targeted proteoform detection and broadscale discovery. He emphasized the tau proteoform assay's ...

OPKO Health, Inc. has announced the initiation of a multi-center clinical validation study for the Company's proprietary Total PSA microfluidic assay cassette running on the Claros® 1 in-office ...